| Literature DB >> 32520417 |
Angélique Kergreis1, Rianne M Lord1,2, Sarah J Pike1,3.
Abstract
A series of cyclometallated mono- and di-nuclear platinum(II) complexes and the parent organic ligand, 2,6-diphenylpyridine 1 (HC^N^CH), have been synthesized and characterized. This library of compounds includes [(C^N^C)PtII (L)] (L=dimethylsulfoxide (DMSO) 2 and triphenylphosphine (PPh3 ) 3) and [((C^N^C)PtII )2 (L')] (where L'=N-heterocycles (pyrazine (pyr) 4, 4,4'-bipyridine (4,4'-bipy) 5 or diphosphine (1,4-bis(diphenylphosphino)butane (dppb) 6). Their cytotoxicity was assessed against four cancerous cell lines and one normal cell line, with results highlighting significantly increased antiproliferative activity for the dinuclear complexes (4-6), when compared to the mononucleated species (2 and 3). Complex 6 is the most promising candidate, displaying very high selectivity towards cancerous cells, with selectivity index (SI) values >29.5 (A2780) and >11.2 (A2780cisR), and outperforming cisplatin by >4-fold and >18-fold, respectively.Entities:
Keywords: anticancer; bioinorganic chemistry; cyclometallated platinum(II); multinuclear complexes; phosphine ligands
Mesh:
Substances:
Year: 2020 PMID: 32520417 PMCID: PMC7756510 DOI: 10.1002/chem.202002517
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236